Could Mean Platelet Volume Serve as a Prognostic Indicator for Outcomes in Cancer?
Researchers sought to determine the predictive value of mean platelet volume as a marker for cancer outcomes.
Researchers sought to determine the predictive value of mean platelet volume as a marker for cancer outcomes.
Many cancer patients may be treated with drugs that were granted accelerated approval but do not provide a clinical benefit, a study suggests.
Artificial intelligence can predict survival in cancer patients using information from a patient’s initial consultation with an oncologist, a study suggests.
Aggregated data can hide disparities in cancer incidence and outcomes among Asian and Native Hawaiian/Pacific Islander patients in the US.
Black cancer patients are less likely than their White counterparts to receive shorter radiotherapy regimens, a study suggests.
Investigators characterized the toxicity of stereotactic body radiotherapy for oligometastases from predominantly prostate, colorectal, breast, and lung cancer.
A novel blood test can detect cancers that currently have no standard screening procedures, a study suggests.
A team of investigators examined the financial burden of breast, lung, colorectal, and prostate cancers for nonelderly adults with private insurance.
Breast cancer risk linked to male-origin infertility; risk also up for men who have not fathered any children
Measuring lymphocytes during or after radiotherapy could provide useful information about infection risk, according to researchers.